Table 1.
Profile of patients with Parkinson’s disease.
| Patient | Disease duration since diagnosis (months) | Most affected upper limb | UPDRS |
Hoehn and Yahr score | Anti-parkinsonian medication | ||
|---|---|---|---|---|---|---|---|
| Motor score part III | Rest hand tremor item 20 | Postural limb tremor item 21 | |||||
| 1 | 90 | Left | 42 | 3 | 1 | 3 | Levodopa (100+25) mg, 2 tabs |
| 2 | 78 | Left | 32 | 3 | 3 | 2.5 | Levodopa (100+25) mg, 2 tabsRotigotine 4 mg, 1 patch |
| 3 | 84 | Right | 32 | 3 | 2 | 3 | Levodopa (100+25) mg, 2 tabs |
| 4 | 60 | Right | 36 | 2 | 3 | 2.5 | Levodopa (100+25) mg, 2 tabsRotigotine 4 mg, 1 patch |
| 5 | 46 | Right | 21 | 2 | 2 | 1.5 | Biperiden 2 mg, 2 tabsLevodopa (100+25) mg, 2 tabs |
| 6 | 6 | Left | 13 | 2 | 1 | 2.5 | Levodopa (100+25) mg, 1 tabRasagiline 1 mg, 1 tab |
| 7 | 12 | Left | 9 | 1 | 1 | 1 | No |
| 8 | 12 | Right | 8 | 2 | 1 | 2 | No |
| 9 | 12 | Left | 9 | 1 | 1 | 2 | No |
| 10 | 78 | Right | 48 | 2 | 3 | 1 | Levodopa (100+25) mg, 1 tabCarbidopa/Levodopa/Entacapone (100/25/200) mg, 4 tabs |
| 11 | 24 | Left | 9 | 1 | 1 | 1 | Levodopa (100+25) mg, 0.5 tabRopinirole 0.25 mg, 2 tab |
| 12 | 12 | Right | 7 | 2 | 1 | 1 | No |
| 13 | 96 | Left | 17 | 1 | 2 | 1 | Carbidopa/Levodopa/Entacapone (100/25/200) mg, 3 tabsRasagiline 1 mg, 1 tab |
| 14 | 24 | Left | 10 | 2 | 1 | 1 | Rasagiline 1 mg, 1 tab |
| 15 | 6 | Right | 7 | 2 | 1 | 2 | No |
| 16 | 90 | Left | 16 | 2 | 2 | 1 | Carbidopa/Levodopa/Entacapone (100/25/200) mg, 3 tabsRasagiline 1 mg, 1 tab |
| 17 | 24 | Right | 7 | 1 | 1 | 1 | Levodopa (100+25) mg, 1 tab |
| 18 | 20 | Left | 21 | 1 | 2 | 1.5 | Rasagiline 1 mg, 1 tab |
| 19 | 6 | Left | 21 | 2 | 2 | 1.5 | No |
| 20 | 18 | Right | 22 | 2 | 2 | 2.5 | No |
| 21 | 32 | Right | 25 | 1 | 1 | 1.5 | Amantadine 100 mg, 2 tabs |
| 22 | 30 | Right | 18 | 1 | 1 | 1 | Levodopa/Carbidopa (100/250) mg, 2 tabsPramipexole 700 mg, 2 tabs |
| 23 | 12 | Left | 10 | 1 | 1 | 1.5 | No |